Guanine nucleotide exchange factors (GEFs) for Rho GTPases are essential regulators of cell behavior by controlling the activation of Rho, Rac, and Cdc42, which regulate actin dynamics, microtubule cytoskeleton, cell polarity, gene expression, and membrane transport. GEFs catalyze the exchange of GDP for GTP, activating Rho GTPases, while GTPase-activating proteins (GAPs) and guanine nucleotide dissociation inhibitors (GDIs) regulate the inactivation and localization of these proteins. The structural features of GEFs include a DH domain necessary for GEF activity and a PH domain that may mediate membrane targeting and interaction with phosphoinositides. Many GEFs also contain additional domains such as SH2, SH3, and PDZ, which help in coupling GEFs to upstream receptors and signaling molecules. GEFs are tightly regulated through intramolecular inhibitory sequences, protein-protein interactions, and changes in subcellular localization. For example, Vav is constitutively activated when its N-terminal sequences are removed, and its activity is regulated by phosphorylation and interactions with PI 3-kinase products. Similarly, Dbl is activated by the removal of its N-terminal sequences, and its activity is regulated by interactions with the PH domain. Other GEFs, such as Tiam1 and Sos1, are regulated by interactions with membrane-bound lipids and signaling molecules. GEFs are also involved in various biological processes, including gastrulation, neuronal morphogenesis, and muscle development. In gastrulation, Rho GEFs are essential for cell shape changes and mesodermal invagination. In neuronal development, GEFs such as Tiam1 and Trio are involved in axon guidance and dendritic spine formation. In muscle development, GEFs like Trio and Obscurin are involved in myoblast fusion and myofibrillogenesis. In the context of human disease, mutations in GEFs have been linked to developmental disorders, neurodegenerative diseases, and cancer. For example, mutations in the Rho GEF Dbl have been associated with certain cancers, and the oncogenic activity of GEFs is thought to be mediated through the deregulated activation of Rho GTPases. The study of GEFs has provided important insights into the regulation of Rho GTPases and their roles in various cellular processes and diseases.Guanine nucleotide exchange factors (GEFs) for Rho GTPases are essential regulators of cell behavior by controlling the activation of Rho, Rac, and Cdc42, which regulate actin dynamics, microtubule cytoskeleton, cell polarity, gene expression, and membrane transport. GEFs catalyze the exchange of GDP for GTP, activating Rho GTPases, while GTPase-activating proteins (GAPs) and guanine nucleotide dissociation inhibitors (GDIs) regulate the inactivation and localization of these proteins. The structural features of GEFs include a DH domain necessary for GEF activity and a PH domain that may mediate membrane targeting and interaction with phosphoinositides. Many GEFs also contain additional domains such as SH2, SH3, and PDZ, which help in coupling GEFs to upstream receptors and signaling molecules. GEFs are tightly regulated through intramolecular inhibitory sequences, protein-protein interactions, and changes in subcellular localization. For example, Vav is constitutively activated when its N-terminal sequences are removed, and its activity is regulated by phosphorylation and interactions with PI 3-kinase products. Similarly, Dbl is activated by the removal of its N-terminal sequences, and its activity is regulated by interactions with the PH domain. Other GEFs, such as Tiam1 and Sos1, are regulated by interactions with membrane-bound lipids and signaling molecules. GEFs are also involved in various biological processes, including gastrulation, neuronal morphogenesis, and muscle development. In gastrulation, Rho GEFs are essential for cell shape changes and mesodermal invagination. In neuronal development, GEFs such as Tiam1 and Trio are involved in axon guidance and dendritic spine formation. In muscle development, GEFs like Trio and Obscurin are involved in myoblast fusion and myofibrillogenesis. In the context of human disease, mutations in GEFs have been linked to developmental disorders, neurodegenerative diseases, and cancer. For example, mutations in the Rho GEF Dbl have been associated with certain cancers, and the oncogenic activity of GEFs is thought to be mediated through the deregulated activation of Rho GTPases. The study of GEFs has provided important insights into the regulation of Rho GTPases and their roles in various cellular processes and diseases.